April/May #163 : Still Gellin' - by Laura Whitehorn

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents
 

The Education of Miss Universe

TAG Team

La Educación de Miss Universo




Still Gellin'

It’s Not Too Late To Start HIV Meds

Try This

Entry Inhibitor Slows Its Advance

Attack of the Killer Popcorn!

A Tale of Two Viruses

Doing the Dose

Ballroom Brotherhood

PEP Rally

Prevention for Positives




POZ Q&A: Miss America

Fly Boy

Infectiously Adorable?

POZ Picks

Texas Baby Bump

Positively Page Turning

Calling All Keyboard Cassanovas

Put a Little PEP in Your Step




Editor's Letter-April/May 2010

Your Feedback

CHAMPS Against HIV



 
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV


Scroll down to comment on this story.


email print

April / May 2010


Still Gellin'

by Laura Whitehorn

At the end of 2009, trial results for PRO 2000, a vaginal gel designed to keep women from contracting HIV, were announced—and they were disappointing. Rates of HIV infection were basically identical for women who used the gel as for those who did not.

Other news, however, suggests that there might still be hope for condomless sex, one day.

Researchers at the University of Pittsburgh received two large grants (total value: nearly $20 million) to study and develop microbicide gels. Best of all, at least one gel will be designed and tested specifically for rectal use. That would be helpful for men who have sex with men, as well as for heterosexual couples who have anal sex.

Pre-exposure prophylaxis (PrEP)—when negative people take antiretroviral meds before exposure to HIV—worked well in mice that had been engineered to have human immune systems. The mice were exposed rectally or intravenously to very high levels of HIV. No mouse treated with PrEP became HIV positive, while 12 of 19 mice that hadn’t been PrEP’d did contract the virus. 

Search: gel, PRO 2000, vaginal, microbicide, rectal, MSM, PrEp, Pre-exposure prophylaxis, antiretroviral,


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (0 total)

 
[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    CuteBoyinQns
    Jackson Heights
    New York


    InDefaultOf
    Seattle
    Washington


    pevans
    San Francisco
    California


    kmfdm221
    Arcata
    California
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Are you a regular coffee drinker?
Yes
No

Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.